biotechnology

biotechnology

We are together in each step

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 238
            [name] => biotechnology
            [slug] => biotechnology
            [term_group] => 0
            [term_taxonomy_id] => 238
            [taxonomy] => post_tag
            [description] =>
            [parent] => 0
            [count] => 23
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 407
            [name] => funding-for-biotechnology
            [slug] => financing-for-biotechnology
            [term_group] => 0
            [term_taxonomy_id] => 407
            [taxonomy] => post_tag
            [description] =>
            [parent] => 0
            [count] => 2
            [filter] => raw
        )

    [2] => WP_Term Object
        (
            [term_id] => 216
            [name] => funding-rounds
            [slug] => financing-rounds
            [term_group] => 0
            [term_taxonomy_id] => 216
            [taxonomy] => post_tag
            [description] =>
            [parent] => 0
            [count] => 12
            [filter] => raw
        )

)

Biotech operations: Minoryx, Suanfarma, Ability Pharma and Oryzon Genomics

20/10 Most relevant acquisitions

According to data provided by Ascri, in the first half of 2015, biotechnology, with 24 operations, is the second [...]

read more >>

Spanish biotech companies internationalise: Artax Biopharma, PharmaMar and Mind The Byte

01/10 Sectoral funding

In the last month we have seen how Spanish companies in the field of biotechnology are growing and opening [...]

read more >>

Biotech investment news September 2015: CaixaIpulse, Sanifit and Centauri Biotech

17/09 Sectoral funding

Good news for funding in the biotech sector in the first half of September, the first half of the year saw the closing of [...]

read more >>

Biotechnology finds a new form of funding with Crowdfunding and Spain is one of the pioneers

23/07 Most active investors

Given the difficulty biotech companies have in finding both private and public funding, it is [...]

read more >>

CDTI's role in Spanish biotechnology

20/07 Sectoral funding

The Cdti is contributing to the development of biotechnology in our country. In the last half of 2014 alone, the [...]

read more >>

Biotechnology grows and finds alternative forms of financing

30/06 Most active investors

According to Asebio, the number of healthcare biotechnology projects developed in Spain grew by 30% in 2015, if we [...]

read more >>

Biotech investment news: Era Biotech, Aura Bioscience, Quirumed and others (March 2015)

13/05 Sectoral funding

In March 2015, the biotech sector in Spain has been the protagonist of several investment operations, both in Spain and abroad.

read more >>

Sendabio with the help of Abra Invest closes investment round

09/04 Sectoral funding

In April 2015, the Basque biotech company Sendabio has closed an investment round with an industrial partner. E [...]

read more >>

Operations Biotechnology February 2015

24/03 Most relevant acquisitions

February 2015 has been an active month for the Biotech sector. Spanish venture capital has carried out operations [...]

read more >>

New developments in biotech funds in Spain (En-2015)

10/02 Most active investors

A small number of venture capitalists specialising in biotechnology are consolidating in Spain. [...]

read more >>

Analysis of the Internet of Things for Health

21/01 Sectoral funding

Accenture said in a report in 2011 that the healthcare sector was going to be the most affected by the development of the Internet [...].

read more >>

« Anterior 1 2

Now, for tomorrow

Baker Tilly Global Deal Advisory trading as Baker Tilly Global Deal Advisory is an independent member of Baker Tilly International. Baker Tilly International Limited is an English company. Baker Tilly International does not provide professional services to its clients. Each member firm is a separate and independent legal entity, and each describes itself as such. Baker Tilly Global Deal Advisory is not the agent of Baker Tilly International and does not have the authority to bind Baker Tilly International or act on behalf of Baker Tilly International. None of Baker Tilly International, Baker Tilly Global Deal Advisory, nor any of the other Baker Tilly International member firms has any liability for the acts or omissions of the others. The Baker Tilly name and associated logo is used under licence from Baker Tilly International Limited.